OncoLens, a clinical decision software that focuses on oncology (cancer care), has closed a $1.35 million seed round led by BIP Capital and Atlanta Technology Angels (ATA). OncoLens was founded by CEO Anju Mathew, formerly head of technology and innovation at McKesson’s Medical Surgical business unit, and Chief